KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

A major achievement with far-reaching implications for treating deadly skin cancer has been discovered by Tel Aviv University ...

The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

This review highlights the potential of natural polysaccharide microneedles in cancer immunotherapy, focusing on localized ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

Immune cells work to fight infection and other diseases. Different subsets work together to elicit a healthy immune response; ...

CAR T cell therapy has transformed blood cancer treatment, but success in solid tumors remains limited by major challenges such as on-target/off-tumor toxicity, poor tumor infiltration, and an ...

Chimeric antigen receptor T (CAR-T) cell therapy has revolutionized hematologic cancer treatment, but its efficacy in solid tumors remains limited by poor infiltration into the complex tumor ...

Gastrointestinal tumors remain a global health challenge, with high incidence and mortality. Among them, colorectal cancer (CRC) carries the heaviest burden and serves as a key model for how the gut ...